178 related articles for article (PubMed ID: 35357426)
21. Variants in melanocortin 1 receptor gene contribute to risk of melanoma--a direct sequencing analysis in a Texas population.
Guan X; Niu J; Liu Z; Wang LE; Amos CI; Lee JE; Gershenwald JE; Grimm EA; Wei Q
Pigment Cell Melanoma Res; 2013 May; 26(3):422-5. PubMed ID: 23360207
[TBL] [Abstract][Full Text] [Related]
22. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G
Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535
[TBL] [Abstract][Full Text] [Related]
23. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S
Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796
[TBL] [Abstract][Full Text] [Related]
24. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
Goldstein AM; Landi MT; Tsang S; Fraser MC; Munroe DJ; Tucker MA
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2208-12. PubMed ID: 16172233
[TBL] [Abstract][Full Text] [Related]
25. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians.
Nan H; Kraft P; Hunter DJ; Han J
Int J Cancer; 2009 Aug; 125(4):909-17. PubMed ID: 19384953
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
Goldstein AM; Chaudru V; Ghiorzo P; Badenas C; Malvehy J; Pastorino L; Laud K; Hulley B; Avril MF; Puig-Butille JA; Miniere A; Marti R; Chompret A; Cuellar F; Kolm I; Mila M; Tucker MA; Demenais F; Bianchi-Scarra G; Puig S; de-Paillerets BB
Int J Cancer; 2007 Aug; 121(4):825-31. PubMed ID: 17397031
[TBL] [Abstract][Full Text] [Related]
27. MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project.
Pasquali E; García-Borrón JC; Fargnoli MC; Gandini S; Maisonneuve P; Bagnardi V; Specchia C; Liu F; Kayser M; Nijsten T; Nagore E; Kumar R; Hansson J; Kanetsky PA; Ghiorzo P; Debniak T; Branicki W; Gruis NA; Han J; Dwyer T; Blizzard L; Landi MT; Palmieri G; Ribas G; Stratigos A; Council ML; Autier P; Little J; Newton-Bishop J; Sera F; Raimondi S;
Int J Cancer; 2015 Feb; 136(3):618-31. PubMed ID: 24917043
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi.
Falchi M; Bataille V; Hayward NK; Duffy DL; Bishop JA; Pastinen T; Cervino A; Zhao ZZ; Deloukas P; Soranzo N; Elder DE; Barrett JH; Martin NG; Bishop DT; Montgomery GW; Spector TD
Nat Genet; 2009 Aug; 41(8):915-9. PubMed ID: 19578365
[TBL] [Abstract][Full Text] [Related]
29. Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes.
Chaudru V; Lo MT; Lesueur F; Marian C; Mohamdi H; Laud K; Barrois M; Chompret A; Avril MF; Demenais F; Bressac-de Paillerets B
Fam Cancer; 2009; 8(4):371-7. PubMed ID: 19484507
[TBL] [Abstract][Full Text] [Related]
30. MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort.
Pellegrini C; Botta F; Massi D; Martorelli C; Facchetti F; Gandini S; Maisonneuve P; Avril MF; Demenais F; Bressac-de Paillerets B; Hoiom V; Cust AE; Anton-Culver H; Gruber SB; Gallagher RP; Marrett L; Zanetti R; Dwyer T; Thomas NE; Begg CB; Berwick M; Puig S; Potrony M; Nagore E; Ghiorzo P; Menin C; Manganoni AM; Rodolfo M; Brugnara S; Passoni E; Sekulovic LK; Baldini F; Guida G; Stratigos A; Ozdemir F; Ayala F; Fernandez-de-Misa R; Quaglino P; Ribas G; Romanini A; Migliano E; Stanganelli I; Kanetsky PA; Pizzichetta MA; García-Borrón JC; Nan H; Landi MT; Little J; Newton-Bishop J; Sera F; Fargnoli MC; Raimondi S; ; ;
Lancet Child Adolesc Health; 2019 May; 3(5):332-342. PubMed ID: 30872112
[TBL] [Abstract][Full Text] [Related]
31. The Melanocortin 1 receptor and its influence on naevi and melanoma in dark-skinned phenotypes.
Smith DJM
Australas J Dermatol; 2019 Aug; 60(3):192-199. PubMed ID: 30585306
[TBL] [Abstract][Full Text] [Related]
32. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population.
Brudnik U; Branicki W; Wojas-Pelc A; Kanas P
Exp Dermatol; 2009 Feb; 18(2):167-74. PubMed ID: 18637131
[TBL] [Abstract][Full Text] [Related]
33. Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population.
Stratigos AJ; Dimisianos G; Nikolaou V; Poulou M; Sypsa V; Stefanaki I; Papadopoulos O; Polydorou D; Plaka M; Christofidou E; Gogas H; Tsoutsos D; Kastana O; Antoniou C; Hatzakis A; Kanavakis E; Katsambas AD
J Invest Dermatol; 2006 Aug; 126(8):1842-9. PubMed ID: 16601669
[TBL] [Abstract][Full Text] [Related]
34. Inherited variation at MC1R and histological characteristics of primary melanoma.
Taylor NJ; Busam KJ; From L; Groben PA; Anton-Culver H; Cust AE; Begg CB; Dwyer T; Gallagher RP; Gruber SB; Orlow I; Rosso S; Thomas NE; Zanetti R; Rebbeck TR; Berwick M; Kanetsky PA
PLoS One; 2015; 10(3):e0119920. PubMed ID: 25790105
[TBL] [Abstract][Full Text] [Related]
35. The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls.
McMeniman EK; Duffy DL; Jagirdar K; Lee KJ; Peach E; McInerney-Leo AM; De'Ambrosis B; Rayner JE; Smithers BM; Soyer HP; Sturm RA
Br J Dermatol; 2020 Aug; 183(2):357-366. PubMed ID: 31794051
[TBL] [Abstract][Full Text] [Related]
36. Integrative genetic analysis suggests that skin color modifies the genetic architecture of melanoma.
Hulur I; Skol AD; Gamazon ER; Cox NJ; Onel K
PLoS One; 2017; 12(10):e0185730. PubMed ID: 28973033
[TBL] [Abstract][Full Text] [Related]
37. Melanoma susceptibility genes.
Newton-Bishop J; Gruis N
Melanoma Res; 2010 Jun; 20(3):161-2. PubMed ID: 20442621
[No Abstract] [Full Text] [Related]
38. Genetic analysis of melanocortin 1 receptor red hair color variants in a Russian population of Eastern Siberia.
Motorina AV; Palkina NV; Komina AV; Ruksha TG; Artyukhov IP; Kozlov VV
Eur J Cancer Prev; 2018 Mar; 27(2):192-196. PubMed ID: 27755135
[TBL] [Abstract][Full Text] [Related]
39. Sporadic melanoma in South-Eastern Italy: the impact of melanocortin 1 receptor (MC1R) polymorphism analysis in low-risk people and report of three novel variants.
Guida S; Bartolomeo N; Zanna PT; Grieco C; Maida I; De Summa S; Tommasi S; Guida M; Azzariti A; Foti C; Filotico R; Guida G
Arch Dermatol Res; 2015 Aug; 307(6):495-503. PubMed ID: 25736238
[TBL] [Abstract][Full Text] [Related]
40. MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair.
Pellegrini C; Fargnoli MC; Suppa M; Peris K
BMC Med Genet; 2012 Sep; 13():81. PubMed ID: 22978401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]